SNYR Synergy CHC Corporation (CE)

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K/A

(Amendment No. 2)

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of Earliest Event Reported): January 22, 2015

 

SYNERGY STRIPS CORP.

(Exact name of registrant as specified in its charter)

 

Nevada		000-55098		99-0379440
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

 

865 Spring Street Westbrook, Maine		04092
(Address of principal executive offices)		(Zip Code)

 

(615) 939-9004

(Registrant’s telephone number, including area code)

 

 

(Former name if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

EXPLANATORY NOTE

  

This Current Report on Form 8-K/A (Amendment No. 2) amends the Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) by Synergy Strips Corp. (the “Company”) on January 27, 2015, as amended by Form 8-K/A filed on February 9, 2015 (the “Original 8-K”) announcing the completion on January 22, 2015 of the acquisition (the “Acquisition”) of substantially all of the assets of Factor Nutrition Labs, LLC (the “Focus Factor Business”), a limited liability company formed under the laws of Delaware.

 

In the Original 8-K, the Company indicated that it would file the historical and pro forma financial information required under Item 9.01 with respect to the Acquisition within 71 days of the due date of the Original 8-K, as permitted by the SEC rules. The Company is now filing this Amendment No. 2 to include the required financial statements and pro forma financial information as a result of the completion of the Acquisition.

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

 

(a)	Financial statements of businesses acquired.

 

The audited historical financial statements of Factor Nutrition Labs, LLC for the years ended December 31, 2014 and 2013 are filed herewith as Exhibit 99.1 and are incorporated herein by reference.

 

(b)	Pro forma financial information.

 

The unaudited pro forma condensed combined financial statements of the Company giving effect to the Acquisition, are filed herewith as Exhibit 99.2 and are incorporated herein by reference.

 

(c)	Shell company transactions.

 

Not applicable

 

(d)

Exhibits

 

Exhibit No		Description
99.1		The audited historical financial statements of Factor Nutrition Labs, LLC for the years ended December 31, 2014 and 2013
99.2		The unaudited pro forma combined financial statements of the Company

  

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

	SYNERGY STRIPS CORP.
Dated: March 30, 2015	By:	/s/ Jack Ross
	Name:	Jack Ross
	Title:	Chief Executive Officer

 

 

 

Exhibit 99.1

 

The Audited historical financial statements of Factor Nutrition Labs, LLC for the years ended December 31, 2014 and 2013.

 

Factor Nutrition Labs, LLC

(A Limited Liability Company)

Audited Financial Statements

 

For the years ending December 31, 2014 and 2013

 

 

INDEX TO FINANCIAL STATEMENTS

 

CONTENTS		PAGE NO.
Report of Independent Registered Public Accounting Firm		F-2
Balance Sheets at December 31, 2014 and 2013		F-3
Statements of Operations for the Years Ended December 31, 2014 and 2013		F-4
Statement of Members’ Capital for the Two Years Ended December 31, 2014 and 2013		F-5
Statements of Cash Flows for the Years Ended December 31, 2014 and 2013		F-6
Notes to the Financial Statements		F-7

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Shareholders

Factor Nutrition Labs, LLC

Westbrook, Maine

 

We have audited the accompanying balance sheets of Factor Nutrition Labs, LLC (the “Company”), as of December 31, 2014 and 2013, and the related statements of operations, members’ capital and cash flows for each of the two years in the period ended December 31, 2014. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

 

We have conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States of America). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Factor Nutrition Labs, LLC as of December 31, 2014 and 2013, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2014, in conformity with accounting principles generally accepted in the United States of America.

 

/s/ RBSM LLP
RBSM LLP
New York, New York
March 27, 2015

 

 

FACTOR NUTRITION LABS, LLC

BALANCE SHEETS

DECEMBER 31, 2014 AND 2013

 

		2014				2013
ASSETS
Current assets
Cash and cash equivalents		$	1,887,658			$	3,814,966
Investment in CD’s			-				355,160
Accounts receivable, net			3,066,082				961,731
Prepaid and other current assets			111,829				166,815
Total current assets			5,065,569				5,298,672
Fixed assets, net of accumulated depreciation of $52,219 and $51,444			-				775
Other assets
Deposits			9,000				9,000
Total other assets			9,000				9,000
TOTAL ASSETS		$	5,074,569			$	5,308,447
LIABILITIES AND MEMBERS’ CAPITAL
Current liabilities
Accounts payable and accrued expenses		$	2,431,881			$	820,379
Total current liabilities			2,431,881				820,379
Total liabilities			2,431,881				820,379
Commitments and contingencies			-				-
Members Capital			2,642,688				4,488,068
TOTAL LIABILITIES AND MEMBERS’ CAPITAL		$	5,074,569				5,308,447

 

See the accompanying notes to these financial statements

 

 

FACTOR NUTRITION LABS, LLC

STATEMENTS OF OPERATIONS

 

		Year ended December 31,
		2014				2013
Revenues:
Gross revenues		$	13,159,237			$	11,092,609
Less: returns, allowances and discounts			473,100				463,438
Total revenue, net			12,686,137				10,629,171
Cost of goods sold			5,324,945				4,810,170
Gross profit			7,361,192				5,819,001
Operating expenses:
Retail promotions and in-store demos			5,311,201				2,597,586
Salaries and benefits			615,325				551,143
General and administrative			663,375				760,617
Bad debts			-				956,134
Depreciation			775				8,697
Total operating expenses			6,590,676				4,874,177
Income from operations			770,516				944,824
Other income (expense):
Other income			6,104				12,336
Income before provision for income taxes			776,620				957,160
Income taxes (benefit)			-				-
Net income		$	776,620			$	957,160

 

See the accompanying notes to these financial statements

 

 

FACTOR NUTRITION LABS, LLC

STATEMENT OF MEMBERS’ CAPITAL

TWO YEARS ENDED DECEMBER 31, 2014

 

		Total Member’s Capital
Balance at December 31, 2012		$	3,872,908
Distributions to members			(342,000	)
Net income			957,160
Balance at December 31, 2013		$	4,488,068
Distributions to members			(2,622,000	)
Net income			776,620
Balance at December 31, 2014		$	2,642,688

 

See the accompanying notes to these financial statements

 

 

FACTOR NUTRITION LABS, LLC

STATEMENTS OF CASH FLOWS

 

		Year ended December 31,
		2014				2013
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income		$	776,620			$	957,160
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation			775				8,697
Bad Debt			-				956,134
Changes in operating assets and liabilities:
Accounts receivable			(2,104,351	)			(493,461	)
Prepaid expenses and other			54,986				20,173
Accounts payable and accrued expenses			1,611,502				(344,257	)
Net cash provided by operating activities			339,532				1,104,446
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from investments in CD’s			355,160				(2,000	)
Net cash provided by (used) in investing activities			355,160				(2,000	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Member distributions			(2,622,000	)			(342,000	)
Net cash used in financing activities			(2,622,000	)			(342,000	)
Net (decrease) increase in cash and cash equivalents			(1,927,308	)			760,446
Cash and cash equivalents, beginning of period			3,814,966				3,054,520
Cash and cash equivalents, end of period		$	1,887,658			$	3,814,966
Supplemental disclosure of cash flow information
Cash paid during the year for:
Interest		$	-			$	-
Income tax		$	-			$	-

 

See the accompanying notes to these financial statements 

 

 

FACTOR NUTRITION LABS, LLC

NOTES TO THE FINANCIAL STATEMENTS

DECEMBER 31, 2014 AND 2013

 

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

A summary of the significant accounting policies applied in the presentation of the accompanying financial statements follows:

 

Organization and nature of operations

 

Factor Nutrition Labs, LLC (the “Company”, “we”, “us” or “our”) is in the business of marketing and selling nutritional supplements to major retailers across the United States.

 

As a limited liability company, the members are not personally liable for any of the debts, obligations, losses, claims, or judgements on any of the liabilities of the Company, whether arising in tort, contract, or otherwise, unless a member has signed a specific guarantee.

 

Use of estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Revenue recognition

 

The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 605, Revenue Recognition (“ASC 605”). ASC 605 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred and/or service has been performed; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Ownership and title of our products pass to customers upon delivery of the products to the customers. Freight billed to customers is presented as revenues, and the related freight costs are presented as cost of goods sold.

  

Cash and cash equivalents

 

For financial statement purposes, the Company considers all highly-liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents.

 

Accounts receivable - trade

 

Accounts receivable are stated net of allowances for possible bad debt and future chargebacks. Management estimates these possible losses based on payment history of specific customers having specific balances, and establishes an allowance for the remaining accounts receivable based on historical experience. Accounts are written off after all reasonable collection efforts have been exhausted and management concludes that likelihood of collection is remote. Any future recoveries are applied against the allowance for doubtful accounts. The Company’s policy is to extend credit to customers that management has determined to be credit worthy.

 

 

FACTOR NUTRITION LABS, LLC

NOTES TO THE FINANCIAL STATEMENTS

DECEMBER 31, 2014 AND 2013

 

Trade accounts receivable and the allowance as of December 31, 2014 and 2013 were as follows:

 

		2014				2013
Trade accounts receivable		$	3,066,082			$	961,731
Allowance			-				-
Trade accounts receivable, net		$	3,066,082			$	961,731

 

The allowance for doubtful account was $0 and $0 at December 31, 2014 and 2013. The Company writes off receivables that are deeded uncollectible. In 2013 management determined there were material balances that were uncollectible due to a launch of a new product that was unsuccessful. These receivables were written off. Total of $956,134 was written off in year 2013. A review of 2014 accounts receivable was performed to determine if an allowance should be accrued for. It was determined that all balances are collectible.

 

Fixed assets

 

Fixed assets are carried at cost. Expenditures for maintenance and repairs are expensed currently, while costs of major additions and betterments are capitalized. The costs of assets sold, retired, or otherwise disposed of, and the related accumulated depreciation, are eliminated from the accounts, and any resulting gain or loss is reflected in income.

 

Depreciation is recorded on a straight-line basis over the estimated useful lives of the respective assets as follows:

 

Computer equipment and software			3-5 years
Office equipment			7 years

 

Inventory

 

Inventory consists of finished goods. The Company’s inventory is stated at the lower of cost (FIFO cost basis) or market. Inventory is shown on the balance sheet net of a reserve, which represents older packaging that may still be used as samples. In year 2013 the Company wrote off $488,700 of obsolete inventory. The Company does not anticipate taking additional inventory reserves in the future.

 

Advertising

 

The Company expenses advertising costs as they are incurred. Advertising expenses amounted to $5,291,652 and $2,645,625 for the years ended December 31, 2014 and 2013, respectively. Advertising consists of the following items: in-store demonstrations, online advertising, print advertising and coupons.

 

Income taxes

 

As a limited liability company, the Company is generally not subject to income taxes. Instead, the members report their distributive share of the Company’s profits and losses on their individual income tax return. A provision for taxes has been made where applicable.

 

Uncertain tax positions

 

The Company recognizes and measures its uncertain tax positions in accordance with FASB ASC 740, Income Taxes. Under that guidance, the Company assesses the likelihood, based on their technical merit, that tax positions will be sustained upon examination based on the facts, circumstances and information available at the end of each period. The measurement of uncertain tax positions is adjusted when new information is available, or when an event occurs that requires a change.

 

 

FACTOR NUTRITION LABS, LLC

NOTES TO THE FINANCIAL STATEMENTS

DECEMBER 31, 2014 AND 2013

 

Recent accounting pronouncements

 

There are various other updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to have a material impact on the Company’s financial position, results of operations or cash flows.

 

NOTE 2 - CONCENTRATION OF CREDIT RISK

 

Cash and cash equivalents

 

The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000. The Company minimizes this risk by placing its cash deposits with major financial institutions. At December 31, 2014 and 2013, the uninsured balances amounted to $1,472,552 and $3,359,478, respectively.

 

Accounts receivable

 

As of December 31, 2014, one customer accounted for 79% of the Company’s accounts receivable. As of December 31, 2013, three customers accounted for 73% of the Company’s accounts receivable.

 

Major customers

 

For the year ended December 31, 2014, two customers accounted for approximately 90% of the Company’s gross revenues. For the year ended December 31, 2013, two customers accounted for approximately 84% of the Company’s gross revenues. Substantially all of the Company’s business is with companies in the United States.

 

Major supplier

 

For the year ended December 31, 2014, the Company’s products were manufactured by two suppliers located in Pittsburgh, Pennsylvania and Tustin, California. For the year ended December 31, 2013, the Company’s products were manufactured by one supplier located in Pittsburgh, Pennsylvania. It is the opinion of management that the product can be produced by other manufacturers and the choice to utilize these suppliers is not a significant concentration.

  

NOTE 3 - FIXED ASSETS

 

At December 31, 2014 and 2013, fixed assets consisted of the following:

 

		2014				2013
Office equipment		$	43,173			$	43,173
Computer software			9,046				9,046
			52,219				52,219
Less: accumulated depreciation			(52,219	)			(51,444	)
Fixed assets, net		$	-			$	775

 

Depreciation expense for the years ended December 31, 2014 and 2013 amounted to $775 and $8,697, respectively.

 

 

FACTOR NUTRITION LABS, LLC

NOTES TO THE FINANCIAL STATEMENTS

DECEMBER 31, 2014 AND 2013

 

NOTE 4 - COMMITMENTS AND CONTINGENCIES

 

Operating leases

 

In November 2014, the Company entered into a non-cancellable operating lease for office and warehouse space located in Westbrook, Maine, that expires on October 31, 2015. From January 1, 2013 through October 31, 2014, the Company had the same operating lease. Rent expense under these leases for the years ended December 31, 2014 and 2013 was $50,472 and $53,477, respectively.

 

Total future minimum annual rental commitments through October 31, 2015 amount to $42,900.

 

Litigation and claims

 

Certain conditions may exists as of the date of the financial statements are issued that may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company’s management and its legal counsel asses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company’s legal counsel evaluates the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable, but is reasonably probable, or is probably but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss, if determinable and material, would be disclosed.

 

Management believes that there are no current legal matters that would have a material effect on the Company’s financial position or results of operations.

 

NOTE 5 - MEMBERS’ EQUITY

 

The Company is owned by 3 members. During the years ended December 31, 2014 and 2013, the Company distributed $2,622,000 and $342,000 to its members, respectively.

 

NOTE 6 - SUBSEQUENT EVENTS

 

In accordance with FASB ASC 855, Subsequent Events, the Company has evaluated subsequent events through March, 20, 2015, the date on which these financial statements were available to be issued.

 

On January 22, 2015 substantially all the assets of the Company were sold to Synergy Strips Corp., is a Nevada based corporation that is in the process of building a portfolio of best-in-class consumer product brands. The aggregate purchase price was $6.0 million, with $4.5 million paid on the closing date, $750,000 to be paid on or before January 20, 2016 and a the final $750,000 to be paid on or before January 20, 2017. The transaction was financed through an agreement with Knight Therapeutics Inc. with a secured loan bearing interest of 15% per annum, plus other considerations. The interest rate will decrease to 13% provided Synergy meets specified equity-fundraising targets. In January 2017 the loan matures and may be extended for up to an additional two years if revenue and profitability milestones are met.

 

 

Exhibit 99.2

 

PRO FORMA FINANCIAL INFORMATION

 

●	Condensed Consolidated Pro Forma Unaudited Balance Sheet as of September 30, 2014
●	Condensed Consolidated Pro Forma Unaudited Statement of Operations for the year ended July 31, 2013
●	Condensed Consolidated Pro Forma Unaudited Statement of Operations for the nine months ended September 30, 2014
●	Notes to Condensed Consolidated Pro Forma Unaudited Financial Statements

 

On January 22, 2015, Synergy Strips Corp., a Nevada corporation (the “Company”) entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Factor Nutrition Labs, LLC, a Delaware limited liability company (the “Seller”),Vita Partners, LLC, RPR Partners, LLC, and Thor Associates, Inc. (each a “Principle Owner”). Pursuant to the Purchase Agreement, the Company purchased all of the assets of the Seller’s line of business and products called FOCUS Factor (the product plus the business related to the product is collectively referred to as the “Focus Factor Business”) and assumed the accounts payable and contractual obligations of the Focus Factor Business for an aggregate purchase price of $6.0 million, with $4.5 million paid on the Closing Date, and $750,000 to be paid on or before January 20, 2016 and an additional $750,000 to be paid on or before January 20, 2017 (the “Acquisition”).

  

The unaudited condensed combined pro forma balance sheet gives effect to the Acquisition as if the Acquisition had taken place on September 30, 2014 and combines the Focus Factor Business audited condensed balance sheet as of December 31, 2014 with the Company’s condensed unaudited balance sheet as of September 30, 2014. The unaudited condensed combined pro forma statements of operations are presented as if the Acquisition had been completed on August 1, 2012 combining the Focus Factor Business condensed audited statement of operations for the year ended December 31, 2013 and the Company’s audited condensed statement of operations for the year ended July 31, 2013 and the Focus Factor Business condensed audited statement of operations for the year ended December 31, 2014 and the Company’s unaudited condensed statement of operations for the nine months ended September 30, 2014.

 

The unaudited pro forma combined statement of operations is presented for illustrative purposes only and, therefore, is not necessarily indicative of the operating results that might have been achieved had the transaction occurred as of an earlier date, nor is it necessarily indicative of the operating results that may be achieved in the future. You should not rely on the pro forma condensed combined financial information as being indicative of the historical results that would have been achieved had the companies always been combined or the future results that the combined companies will experience after the Acquisition.

 

The unaudited pro forma combined statement of income, including the notes thereto, should be read in conjunction with the Company’s audited historical consolidated financial statements for the year ended December 31, 2013 included in our Annual Report on Form 10-K for the year ended December 31, 2013, as well as the Seller’s audited financial statements for the years ended December 31, 2014 September 30, 2014 and 2013 included in Exhibit 99.1 to this Form 8-K.

 

 

Synergy Strips Corp.

Unaudited Pro Forma Balance Sheet

September 30, 2014

 

		Balance Sheet Synergy Strips Corp. September 30, 2014				Balance Sheet Factor Nutrition Labs, LLC December 31, 2014				Pro Forma Adjustments								Balance Sheet Consolidated Pro Forma September 30, 2014
										Dr				Cr
Assets
Current Assets
Cash and cash equivalents		$	11,937			$	1,887,658				1,210,955	(1)					$	3,110,550
Accounts receivable			150				3,066,082											3,066,232
Inventory			30,500				-											30,500
Prepaid expenses			30,000				111,829											141,829
Total current assets			72,587				5,065,569											6,349,111
Other assets
Debt issuance costs											289,044	(1)						289,044
Goodwill and intangibles											3,357,313	(1)						3,357,313
Deposits			-				9,000											9,000
Total other assets							9,000											3,655,357
Total Assets		$	72,587			$	5,074,569										$	10,004,468
Liabilities and Stockholders’/Members’ Equity
Current liabilities
Accounts payable and accrued liabilities		$	25,756			$	2,431,881										$	2,457,637
Notes payable			11,200												7,500,000	(1)		7,511,200
Total liabilities			36,956				2,431,881											9,968,837
Stockholders’/Members’ Equity
Common stock, $0.00001 par value; 300,000,000 and 75,000,000 shares authorized, respectively; 62,100,000 and 180,000,000 shares issued and outstanding, respectively			621				-											621
Common stock to be issued			28,000				-											28,000
Additional paid in capital			868,744				3,339,049				3,339,049	(1)						868,744
Shareholder distributions			-				(5,174,757	)							5,174,757	(1)		-
Accumulated equity (deficit)			(861,734	)			4,478,396				4,478,396	(1)						(861,734)
Total stockholders’/members’ equity			35,631				2,642,688											35,631
Total liabilities and stockholders’/members’ equity		$	72,587			$	5,074,569										$	10,004,468

 

(1)	To record the issuance of $7,500,00 of debt in connection with the acquisition of Factor Nutrition Labs, LLC and eliminate the Factor Nutrition Labs, LLC members’ equity as of September 30, 2014.

 

 

Synergy Strips Corp.

Unaudited Pro Forma Statement of Operations

Year ended July 30, 2013

 

		Synergy Strips Corp. Year ended July 31, 2013				Factor Nutrition Labs, LLC Year ended December 31, 2013				Pro Forma Adjustments				Consolidated Pro Forma year ended July 31, 2013
Revenue
Gross revenues		$	-			$	11,092,609							$	11,092,609
Less: returns, allowances and discounts			-				463,438								463,438
Total revenue, net			-				10,629,171								10,629,171
Cost of goods sold			-				4,810,170								4,810,170
Gross profit			-				5,819,001								5,819,001
Operating expenses
Retail promotions and in-store demos			-				2,597,586								2,597,586
Salaries and benefits			-				551,143								551,143
General and administrative			21,783				760,617								782,400
Bad debts			-				956,134								956,134
Depreciation			-				8,697								8,697
Total operating expenses			21,783				4,874,177								4,895,960
Income (loss) from operations			(21,783	)			944,824								923,041
Other income			-				12,336								12,336
Imputed interest expense			1,418				-								1,418
Amortization of debt issuance costs			-				-				144,522	(2)			144,522
Interest expense			-				-				801,217	(2)			801,217
Net income (loss)		$	(23,201	)		$	957,160							$	(11,780	)
Net loss per share - basic and diluted		$	(0.0	)			-							$	(0.0	)
Weighted average common shares - basic and diluted			5,096,541				-								5,096,541

 

(2)	To record interest expense and amortization of debt issuance costs in connection with the debt issuance of $7,500,000.

 

 

Synergy Strips Corp.

Unaudited Pro Forma Statement of Operations

Nine months ended September 30, 2014

 

		Synergy Strips Corp. Nine months ended September 30, 2014				Factor Nutrition Labs, LLC year ended December 31, 2014				Pro Forma Adjustments				Consolidated Pro Forma Nine months ended September 30, 2014
Revenue
Gross revenues		$	2,748			$	13,159,237							$	13,161,985
Less: returns, allowances and discounts			-				473,100								473,100
Total revenue, net			2,748				12,686,137								12,688,885
Cost of goods sold			1,685				5,324,945								5,326,630
Gross profit			1,063				7,361,192								7,362,255
Operating expenses
Retail promotions and in-store demos			-				5,311,201								5,311,201
Salaries and benefits			-				615,325								615,325
General and administrative			787,858				663,375								1,451,233
Depreciation			-				775								775
Total operating expenses			787,858				6,590,676								7,378,534
Income (loss) from operations			(786,795	)			770,516								(16,279	)
Other income			-				6,104								6,104
Amortization of debt issuance costs			-				-				144,522	(2)			144,522
															-
Interest expense			-				-				604,881	(2)			604,881
Net income (loss)		$	(786,795	)		$	776,620							$	(759,578	)
Net loss per share - basic and diluted		$	(0.01	)			-							$	(0.01	)
Weighted average common shares - basic and diluted			108,850,549				-								108,850,549

 

(2)	To record interest expense and amortization of debt issuance costs in connection with the debt issuance of $7,500,000.

 

  

SYNERGY STRIPS CORP.

NOTES TO CONDENSED PRO FORMA UNAUDITED FINANCIAL STATEMENTS

 

Unaudited Pro Forma Condensed Financial Information.

 

The unaudited pro forma financial statements have been prepared in order to present consolidated financial position and results of operations of the Company and Factor Nutrition Labs LLC as if the Acquisition had occurred as of September 30, 2014 for the pro forma condensed consolidated balance sheet and to give effect to the Acquisition as if the transaction had taken place at August 1, 2012 for the pro forma condensed consolidated statement of operations for the year ended July 31, 2013 and the nine months ended September 30, 2014, respectively.

 

The acquisition has been accounted for under the acquisition method of accounting. Under the acquisition method of accounting, the total acquisition consideration price is allocated to the assets acquired and liabilities assumed based on their preliminary estimated fair values. The fair value measurements utilize estimates based on key assumptions of the acquisition, and historical and current market data. The excess of the purchase price over the total of estimated fair values assigned to tangible and identifiable intangible assets acquired and liabilities assumed is recognized as goodwill. In order to ultimately determine the fair values of tangible and intangible assets acquired and liabilities assumed for Factor Nutrition Labs LLC, we may engage a third party independent valuation specialist; however as of the date of this report, the valuation has not been undertaken. During the measurement period (which is the period required to obtain all necessary information that existed at the acquisition date, or to conclude that such information is unavailable, not to exceed one year), additional assets or liabilities may be recognized, or there could be changes to the amounts of assets or liabilities previously recognized on a preliminary basis, if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in the recognition of those assets or liabilities as of that date. The Company expects the purchase price allocations for the acquisition of Factor Nutrition Labs LLC to be completed by September 30, 2015.

  

The pro forma adjustments do not reflect the amortization of intangible assets acquired, if any, in the acquisition.

 

In connection with the financing of the Acquisition, the Company issued a warrant to the lender that entitles the lender to purchase 4,595,187 shares of the Company’s common stock with an aggregate exercise price of $1.00. The lender exercised the warrant on January 22, 2015.

 

In addition, the Company issued to the lender a warrant to purchase 3,584,759 shares of the Company’s common stock on or prior to the close of business of January 22, 2025 with an exercise price of $0.34 per share.

 

The Company believes the warrants issued to the lender have nominal value and the pro forma adjustments do not reflect the issuance of the warrants. In order to ultimately determine the fair values of the warrants issued to the lender , we may engage a third party independent valuation specialist; however as of the date of this report, the valuation has not been undertaken.

 

The following pro forma adjustments are incorporated into the pro forma condensed consolidated balance sheet as of September 30, 2014 and the pro forma condensed consolidated statement of operations for the year ended July 31, 2013 and the nine months ended September 30, 2014 , respectively.

 

The pro forma balance sheet condensed balance sheet is presented using the Company’s September 30, 2014 balance sheet with the Factor Nutrition Labs LLC balance sheet as of December 31, 2014; due to the minimal operations of the Company , adjusting the Factor Nutrition Labs LLC balance sheet to September 30, 2014 is impractical and has not been presented.

 

The pro forma condensed statement of operations for the Company’s fiscal year is presented using the Company’s July 31 2013 statement of operations with Factor Nutrition Labs LLC’s fiscal year statement of operations for the year ended December 31, 2013; subsequent to the issuance of its July 31, 2013 financial statement, the Company changed its fiscal year end to December 31, 2013. Due to the minimal operations of the Company , adjusting the Factor Nutrition Labs LLC statement of operations to a fiscal year ended July 31, 2013 is impractical and has not been presented.

 

The pro forma condensed statement of operations for the Company’s nine months ended September 30, 2014 is presented using the Company’s September 30, 2014 unaudited statement of operations with Factor Nutrition Labs LLC’s fiscal year statement of operations for the year ended December 31, 2014; the difference in the periods is less than 93 days of the Company’s most recent reporting period and therefore, we have not adjusted the Factor Nutrition Labs LLC statement of operations to a fiscal year ended December 31, 2014.